Thomas J. Kiernan - Publications, H-index & Citations

Thomas J. Kiernan

University of Limerick

23H指数

298论文数

1.8K被引数

收录论文 47

发表时间

Clinical outcomes in young patients, <45 years old, following acute myocardial infarction, a single centre analysis

HEART

IF4.4

2023-10-11

OAAI

Waters, M.; Twomey, D.; Pollock, A.; Mcdermott, B.; O'Connor, C.; Ahern, C.; Arnous, S.; Kiernan, T.

Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics

HEART

IF4.4

2023-10-11

OAAI

Soh, B. W. T.; Forkin, A.; Langille, J.; Gracias, C. S.; O'Connor, P.; Pollock, A.; Arnous, S.; Kiernan, T.

Post-percutaneous coronary intervention CYP2C19 genotyping in an Irish population: The potential role in identifying clopidogrel therapy-related bleeding risks

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2023-03-23

OAAI

Soh, Bing Wei Thaddeus; Cusack, Ronan; Waters, Max; O'Connor, Cormac; Arnous, Samer; Kiernan, Thomas

A distinctive posterior mitral valve infective endocarditis and a large mycotic aneurysm

CLINICAL MEDICINE

IF3.9

2023-03-01

OAAI

Alidrous, Fatma; Manjila, Ignatius; Balfe, Christopher; Kiernan, Thomas; Arnous, Samer

SHOCKWAVE INTRAVASCULAR LITHOTRIPSY AS AN ADJUNCT TO PERCUTANEOUS CORONARY INTERVENTION IN CALCIFIED CORONARY LESIONS: A 2 YEAR, SINGLE CENTRE EXPERIENCE

HEART

IF4.4

2021-10-07

OAAI

Muragagha, H.; Millar, K.; Soh, B. Wei; Ullah, I.; Hennessy, T.; Arnous, S.; Kiernan, T.

IS INTRACARDIAC ECHO GUIDED LEFT ATRIAL APPENDAGE OCCLUSION A SAFE AND COST EFFECTIVE ALTERNATIVE TO TRANSOESOPHAGEAL GUIDED LEFT ATRIAL APPENDAGE OCCLUSION? A SINGLE CENTRE RETROSPECTIVE REVIEW

HEART

IF4.4

2021-10-07

OAAI

Millar, K.; Gallen, R.; Goh, Y.; Muradagha, H.; McKittrick, M.; Kiernan, T.; Arnous, S.

THE EFFECT OF COVID-19 LOCKDOWN ON STEMI PRESENTATIONS: AN EARLY PHASE ANALYSIS

HEART

IF4.4

2020-09-30

PREAI

Chongprasertpon, N.; Coughlan, J. J.; Arockiam, S.; Arnous, S.; Kiernan, T.

Diagnosing, fast and slow

POSTGRADUATE MEDICAL JOURNAL

IF2.7

2020-06-28

PREAI

Coughlan, J. J.; Mullins, Cormac Francis; Kiernan, Thomas J.

THE RACE TO REPERFUSION: DETERMINANTS OF TOTAL ISCHAEMIC TIME IN AN IRISH STEMI POPULATION

HEART

IF4.4

2019-10-16

PREAI

O'Connor, C.; Maguire, C.; Ibrahim, A.; Kumar, R.; Kumar, J.; Buckley, A.; Ahearne, C.; Cahill, C.; Hennessy, T.; Arnous, S.; Kiernan, T.

YOUNG AT HEART: RISK FACTOR ASSESSMENT OF YOUNG ADULTS (≤45) WITH ST ELEVATED MYOCARDIAL INFARCTION

HEART

IF4.4

2019-10-16

PREAI

Kumar, R.; Kumar, J.; O'Connor, C.; Sankhyan, N.; Malik, I.; Shakoor, M. N.; Zaman, J.; Turner, E.; Buckley, A.; Maloney, A.; Arnous, S.; Kiernan, T.

STEMI CARE IN OCTOGENARIANS AND NONAGENARIANS: A 5-YEAR REVIEW FROM AN IRISH PPCI CENTRE

HEART

IF4.4

2019-10-16

PREAI

Connor, C. O.; Kumar, R.; Chongprasertpon, N.; Buckley, A.; Kumar, J.; Murphy, L.; Arnous, S.; Kiernan, T.

ABNORMAL DIURNAL BLOOD PRESSURE VARIABILITY IN PATIENTS WITH RECENT DELIRIUM

AGE AND AGEING

IF7.1

2019-02-07

OAAI

Shanahan, E.; Carew, S.; Costelloe, A.; Sheehy, T.; Kiernan, T.; Peters, C.; Lyons, D.; O'Connor, M.

PRE PRIMARY PERCUTANEOUS CORONARY INTERVENTION TIMI FLOW GRADES IN STEMI PATIENTS PRE-LOADED WITH TICAGRELOR

HEART

IF4.4

2018-10-01

PREAI

Jan, Z.; Ullah, I.; Ibrahim, M.; Kiernan, T.

A COMPARISON OF FFR AND IFR ASSESSMENT OF INTERMEDIATE CORONARY LESIONS

HEART

IF4.4

2018-10-01

PREAI

Fitzgerald, G.; Kiernan, T.

ROTATIONAL ATHERECTOMY IN THE MODERN CARDIAC CATHETERISATION LABORATORY PATIENT DEMOGRAPHICS, PROCEDURAL CHARACTERISTICS AND CLINICAL OUTCOMES

HEART

IF4.4

2018-10-01

PREAI

Coughlan, J. J.; Arnous, S.; Kiernan, T.

RETROSPECTIVE ANALYSIS OF THE EFFECTIVENESS OF NURSE-LED CLINIC FOR PATIENTS POST PERCUTANOUS CORONARY INTERVENTION

HEART

IF4.4

2018-10-01

PREAI

Ibrahim, A.; Heelan, M.; Coffey, J.; McElligott, H.; Coyne, C.; Cahill, C.; Mannix, K.; Ahern, C.; Kiernan, T.

FACTORS INFLUENCING TOTAL ISCHAEMIC TIME IN STEMI

HEART

IF4.4

2018-10-01

PREAI

Fitzgerald, G.; Ibrahim, A.; Coffey, J.; Saunders, J.; Cahill, C.; Satti, Z.; Ullah, I.; Kiernan, T.

CAN WE DO BETTER IN IMPROVING END OF LIFE CARE AND SYMPTOM CONTROL IN END-STAGE HEART FAILURE?

HEART

IF4.4

2017-10-05

PREAI

Voon, V.; Chew, S.; Craig, C.; White, D.; Wong, E.; Cahill, C.; Meany, B.; Twomey, F.; Kiernan, T.

STEMI PATIENTS WITH EJECTION FRACTION 35 PERCENT OR LESS; PERCENT IMPROVEMENT, AVERAGE TIME TO IMPROVEMENT AND OUTCOMES 2014-2017, 2017

HEART

IF4.4

2017-10-05

PREAI

Blake, N.; Lobo, R.; Mannix, K.; Ahern, C.; Arnous, S.; Abbas, S.; Hennessy, T.; Ullah, I.; Brennan, A.; Kiernan, T.

The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban)

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2017-06-13

PREAI

O'connor, Cormac T.; Kiernan, Thomas J.; Yan, Bryan P.

研究方向